EGFR and neoplasm: From all 29 different mutations detectable by both NGS panels (plasma and tumor), seven different variants (24.13%; EGFR L858R in two patients, KRAS G13D and Q61H and TP53 G244D, V197M, R213P, and R273H) were detected only in plasma and not in the tumor itself.